Keryx Biopharmaceuticals (Keryx Biopharmaceuticals) Gross-Profit-to-Asset % : 52.89% (As of Sep. 2018)

Keryx Biopharmaceuticals Gross-Profit-to-Asset % Chart

Keryx Biopharmaceuticals Annual Data
	Trend	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
Gross-Profit-to-Asset %		Get a 7-Day Free Trial					17.65	12.57	3.88	-4.35	23.72

Keryx Biopharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															18.55	25.02	30.70	48.53	52.89

Competitive Comparison of Keryx Biopharmaceuticals's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Keryx Biopharmaceuticals's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Keryx Biopharmaceuticals's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keryx Biopharmaceuticals's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Keryx Biopharmaceuticals's Gross-Profit-to-Asset % falls into.

Keryx Biopharmaceuticals Gross-Profit-to-Asset % Calculation

Keryx Biopharmaceuticals's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2017 is calculated as:

Keryx Biopharmaceuticals's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2018 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2018) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Keryx Biopharmaceuticals Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Keryx Biopharmaceuticals's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Keryx Biopharmaceuticals (Keryx Biopharmaceuticals) Business Description